BlackRock Health Sciences Trust (NYSE:BME) Sees Large Increase in Short Interest

BlackRock Health Sciences Trust (NYSE:BME) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 7,400 shares, a growth of 19.4% from the November 30th total of 6,200 shares. Based on an average daily volume of 46,500 shares, the days-to-cover ratio is currently 0.2 days.

BlackRock Health Sciences Trust Trading Down 0.4 %

Shares of BlackRock Health Sciences Trust stock traded down $0.15 on Friday, hitting $38.32. 74,942 shares of the company traded hands, compared to its average volume of 36,073. BlackRock Health Sciences Trust has a 52 week low of $36.87 and a 52 week high of $42.86. The business has a 50-day simple moving average of $39.50 and a 200 day simple moving average of $40.68.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently declared a monthly dividend, which was paid on Monday, December 23rd. Shareholders of record on Monday, December 16th were issued a $0.2621 dividend. The ex-dividend date of this dividend was Monday, December 16th. This represents a $3.15 dividend on an annualized basis and a yield of 8.21%.

Institutional Trading of BlackRock Health Sciences Trust

Several hedge funds have recently bought and sold shares of BME. Fountainhead AM LLC bought a new stake in shares of BlackRock Health Sciences Trust in the third quarter worth about $204,000. City of London Investment Management Co. Ltd. purchased a new position in BlackRock Health Sciences Trust during the 2nd quarter valued at approximately $429,000. Logan Stone Capital LLC purchased a new position in BlackRock Health Sciences Trust during the 2nd quarter valued at approximately $600,000. Consolidated Portfolio Review Corp increased its stake in BlackRock Health Sciences Trust by 133.8% in the 2nd quarter. Consolidated Portfolio Review Corp now owns 39,721 shares of the company’s stock worth $1,623,000 after acquiring an additional 22,729 shares during the last quarter. Finally, Raymond James & Associates raised its holdings in shares of BlackRock Health Sciences Trust by 7.0% during the 2nd quarter. Raymond James & Associates now owns 44,877 shares of the company’s stock worth $1,833,000 after acquiring an additional 2,931 shares in the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.